Related Experiment Video
Updated: Feb 2, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Targeting PUMA/Bcl-xL interaction by new specific compounds to unleash apoptotic process in cancer cells
Appala Venkata Ramana Murthy1, Vennu Narendar2, Nangunoori Sampath Kumar2
1Chemveda Life Sciences India Pvt. Ltd, #B-11/1, IDA Uppal, Hyderabad, 500039, Telangana, India; Jawaharlal Nehru Technological University Hyderabad, Kukatpally, Hyderabad, 500 085, Telangana, India.
Abstract:
We describe the first examples of small molecules able to disrupt the nanomolar interaction between the pro-apoptotic protein PUMA and its anti-apoptotic counterpart BcL-xL in malignant cells. Based on molecular modelling studies, we propose a rationale to this result, through a new "bottle-opener"-type strategy which could be of general use in the area of protein-protein interaction studies.
Related Concept Videos
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Molecules and Compounds
Organic Compounds
Coordination Compounds and Nomenclature
Solubility of Ionic Compounds

